Novartis (NVS) – tečaj delnic in novice

Simboli Simboli	Cena	Sprememba	Odstotna sprememba	Trend	Prejšnja končna cena	Odpri	Visoka	Nizka	Promet	Tržna kapitalizacija
SIXB Materials SIXB Materials	SIXB +0,25%	1.104,10	+2,73	+0,25%	—	1.101,37	1.103,63	1.105,31	1.091,41	—	—
SIXC Communications SIXC Communications	SIXC −1,50%	604,16	−9,19	−1,50%	—	613,35	613,35	613,35	601,49	—	—
SIXE Energy SIXE Energy	SIXE −0,09%	1.197,81	−1,02	−0,09%	—	1.198,83	1.199,68	1.199,75	1.182,41	—	—
SIXI Industrials SIXI Industrials	SIXI −0,88%	1.740,41	−15,54	−0,88%	—	1.755,95	1.754,06	1.756,03	1.734,69	—	—
SIXM Financials SIXM Financials	SIXM −0,64%	634,44	−4,07	−0,64%	—	638,51	637,41	637,41	633,05	—	—
SIXR Staples SIXR Staples	SIXR −0,31%	840,90	−2,62	−0,31%	—	843,52	843,35	846,40	837,93	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,38%	215,13	−0,82	−0,38%	—	215,95	215,95	216,84	215,06	—	—
SIXT Technology SIXT Technology	SIXT +2,86%	3.228,71	+89,80	+2,86%	—	3.138,91	3.189,30	3.230,85	3.174,76	—	—
SIXU Utilities SIXU Utilities	SIXU +0,16%	935,87	+1,50	+0,16%	—	934,37	934,72	938,26	927,50	—	—
SIXV Health care SIXV Health care	SIXV −1,37%	1.457,12	−20,31	−1,37%	—	1.477,43	1.474,12	1.474,12	1.451,80	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0,83%	2.399,84	+19,65	+0,83%	—	2.380,19	2.389,34	2.403,04	2.380,47	—	—

NVS:BCBA

Novartis

10.800,00 ARS

0,00%

(0,00) 1D

19. apr., 16:40:36 GMT -3 · ARS

Vsi simboli

TLDD

MAKS

	Simbol	Cena	Sprememba	Odstotna sprememba

Generiranje najpomembnejših vpogledov za NVS …

Tržna kapitalizacija

297,38 mrd.

Promet

0,00

Št. izdanih delnic

2,03 mrd.

Št. zaposlenih

75 tis.

Podobne delnice

Novice

Iz virov v spletu

TradingView

pred 1 dnevom

Novartis AG expected to post earnings of $2.00 a share - Earnings Preview

Yahoo Finance

pred 1 dnevom

Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants

Endpoints News

pred 1 dnevom

Novartis built a big business around delivering radioactive cancer treatments. Can a generic compete?

CNBC

pred 4 tedni

Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week

Profil

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia

Vizitka: Novartis

Generalni direktorVasant Narasimhan

Št. zaposlenih75,3 tis.

Ustanovljeno29. feb. 1996

SedežBasel, Basel, Švica

Sektor-

Spletno mestonovartis.com

Vse vrednosti v valuti USD	mar. 2025	jun. 2025	sep. 2025	dec. 2025
Prihodek	13,62 mrd.	14,84 mrd.	14,36 mrd.	13,86 mrd.
Strošek prodanega blaga	3,22 mrd.	3,32 mrd.	3,54 mrd.	3,54 mrd.
Stroški materiala in storitev	3,22 mrd.	3,32 mrd.	3,54 mrd.	3,54 mrd.
Stroški raziskav in razvoja	2,37 mrd.	2,62 mrd.	2,86 mrd.	2,84 mrd.
Skupni stroški raziskav in razvoja	-	-	-	-
Stroški prodaje, splošni in administrativni stroški	3,06 mrd.	3,44 mrd.	3,30 mrd.	3,44 mrd.
Operativni strošek	5,58 mrd.	6,05 mrd.	6,24 mrd.	6,46 mrd.
Skupni operativni stroški	8,80 mrd.	9,37 mrd.	9,77 mrd.	10,00 mrd.
Prihodek iz poslovanja	4,82 mrd.	5,46 mrd.	4,58 mrd.	3,86 mrd.
Drug prihodek, ki ne izhaja iz poslovanja	46,00 mio.	−13,00 mio.	−7,00 mio.	−130,00 mio.
Zaslužek pred obdavčitvijo z vključenimi izrednimi postavkami	4,41 mrd.	4,53 mrd.	4,20 mrd.	3,22 mrd.
Zaslužek pred obdavčitvijo brez izrednih postavk	4,59 mrd.	5,16 mrd.	4,29 mrd.	3,49 mrd.
Odhodek iz obdavčitve dobička	798,00 mio.	507,00 mio.	266,00 mio.	814,00 mio.
Dejanska davčna stopnja	18,11 %	11,19 %	6,34 %	25,30 %
Drugi operativni stroški	148,00 mio.	−4,00 mio.	70,00 mio.	190,00 mio.
Čisti prihodek	3,61 mrd.	4,04 mrd.	3,93 mrd.	2,41 mrd.
Neto stopnja dobička	26,48 %	27,24 %	27,36 %	17,38 %
Čisti dobiček na delnico	2,28	2,42	2,25	2,03
Prihodki iz obresti in naložb	-	-	-	373,00 mio.
Obrestni odhodki	−270,00 mio.	−289,00 mio.	−281,00 mio.	−304,00 mio.
Neto obrestni odhodki	−270,00 mio.	−289,00 mio.	−281,00 mio.	69,00 mio.
Stroški amortizacije	-	-	-	-
EBITDA	5,91 mrd.	6,56 mrd.	5,78 mrd.	4,96 mrd.
Dobiček ali izguba pri prodaji sredstev	22,00 mio.	−67,00 mio.	81,00 mio.	80,00 mio.

Vsebina z UI lahko vsebuje napake. Več o tem

PomočPošljite povratne informacijeZasebnost Pogoji Zavrnitev odgovornosti

Finance

Raziskovanje